INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 54 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $30,491,000 | 15.27% |
| RHO CAPITAL PARTNERS INC | 2,870,584 | $26,983,000 | 8.96% |
| Private Capital Advisors, Inc. | 293,000 | $2,754,000 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 295,000 | $2,773,000 | 0.35% |
| Meditor Group Ltd | 51,111 | $480,000 | 0.25% |
| EverPoint Asset Management, LLC | 825,000 | $7,755,000 | 0.20% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,392,000 | 0.16% |
| EAM Investors, LLC | 99,428 | $935,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 26,800 | $252,000 | 0.14% |
| Tekla Capital Management LLC | 425,000 | $3,995,000 | 0.14% |